Skip to main content
ConductScienceScienceDex

Nupam P Mahajan

NIH Rank #6098
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8554632Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Surgery

NIH Funding · FY2025

Linked Award Amount
$2.1M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#6,098
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Nupam P Mahajan. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Nupam P Mahajan as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA286443-02R01
    Phase 1 First in Human Trial to Assess Safety and Tolerability of the Novel ACK1 Inhibitor (R)-9b in Patients with Prostate Cancer
    Washington University in St. Louis
    $643.8K
    award amount
  • 5R01CA285526-02R01
    Regulation of Androgen Receptor by NXTAR Long non-coding RNA in Prostate Cancer and its Therapeutic Implications
    Washington University in St. Louis
    $530.3K
    award amount
  • 5R01CA276502-03R01
    Targeting a Novel Signaling Nexus pACK/pCSK/pLCK in Immune Checkpoint Blockade (ICB)-Resistant Prostate Cancer
    Washington University in St. Louis
    $484.4K
    award amount
  • 5R01CA273054-03R01
    Regulation of Mitochondrial Metabolism by Tyr-phosphorylated ATP Synthase Alpha-Subunit and its Therapeutic Implications in Prostate Cancer
    Washington University in St. Louis
    $462.6K
    award amount

Award organization

Organizations that administered FY2025 awards listing Nupam P Mahajan as a PI.

FY2025 award administered by Washington University in St. Louis (MO).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Washington University in St. Louis
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4894
  6. 2024
    Entered Top 25% Nationally
    Ranked #4894
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Nupam P Mahajan.

Kiran Mahajan
Washington University in St. Louis
4
shared awards

Explore further

Find collaborators for Nupam P Mahajan

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →